Stoke Therapeutics Inc (NASDAQ:STOK)

3.56
Delayed Data
As of Oct 04
 -0.02 / -0.56%
Today’s Change
3.37
Today|||52-Week Range
16.48
-61.43%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2018
Quarter 1
2019

--

--
Revenue and IncomeNet Revenues0.000.00------
Depreciation And Amortization32.0K80.0K----
 
 
 
 
Operating ExpensesGross Income-32.0K-80.0K----
 
 
 
General Expenses1.9M6.2M----
 
 
 
Research And Development1.2M4.1M----
 
 
 
Total Operating Expenses1.9M6.3M----
 
 
 
 
Non-Operating ExpensesOperating Income-1.9M-6.3M----
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.9M-5.7M----
 
 
 
Net Income-1.9M-5.7M----
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS31.3M31.3M----
 
 
 
Shares To Calculate EPS Diluted31.3M31.3M----
 
 
 
 
Earnings Per ShareEPS-$0.06-$0.18----
 
 
 
EPS Diluted-$0.06-$0.18----